Premium
Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs
Author(s) -
ALVAREZ L.,
LIFSCHITZ A.,
ENTROCASSO C.,
MANAZZA J.,
MOTTIER L.,
BORDA B.,
VIRKEL G.,
LANUSSE C.
Publication year - 2008
Publication title -
journal of veterinary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 60
eISSN - 1365-2885
pISSN - 0140-7783
DOI - 10.1111/j.1365-2885.2008.00953.x
Subject(s) - ivermectin , albendazole , corriedale , anthelmintic , pharmacokinetics , pharmacology , chemistry , bioavailability , dose , cmax , medicine , zoology , biology , veterinary medicine , surgery
Mixtures of drugs from different chemical families have been proposed as a valid strategy to delay the development of anthelmintic resistance. The current work summarizes the outcome of the evaluation of the plasma disposition kinetics of albendazole (ABZ) and ivermectin (IVM) administered either alone or co‐administered to lambs infected with gastrointestinal (GI) nematodes resistant to both anthelmintic molecules. Thirty six (36) Corriedale lambs naturally infected with multiple resistant GI nematodes were allocated into six treatment groups: (a) ABZ intravenous (ABZ IV ); (b) IVM IV ; (c) ABZ IV + IVM IV ; (d) ABZ intraruminal (IR); (e) IVM subcutaneous (SC) and (f) ABZ IR + IVM SC . Plasma samples were collected over 15 days post‐treatment and analysed by HPLC. The estimated pharmacokinetic (PK) parameters were statistically compared using parametric and non‐parametric statistical tests. The presence of IVM did not affect the plasma disposition kinetics of ABZ and its metabolites after the i.v. administration. However, the ABZ sulphoxide (ABZSO) area under the concentration vs. time curve (AUC) was significantly lower ( P < 0.01) after the intraruminal (i.r.) administration of ABZ alone compared to that obtained for the combined treatment with IVM [subcutaneous (s.c.) injection]. The IVM plasma AUC obtained after its i.v. co‐administration with ABZ was 88% higher ( P < 0.05) compared to the treatment with IVM alone. Any marked difference on IVM PK parameters was observed between the treatments ABZ + IVM and IVM alone injected subcutaneously. The data obtained here indicate that the co‐administration of ABZ and IVM does not induce an adverse kinetic interaction. This type of pharmacology‐based evaluation of drug interactions is becoming highly relevant as drug combinations are now widely used as an alternative to control resistant helminth parasites in livestock.